文献速递睡眠呼吸障碍咽喉与嗓音

舌下神经刺激器植入术中医源性气胸:大型数据库分析

Iatrogenic Pneumothorax During Hypoglossal Nerve Stimulator Implantation: A Large Database Analysis.
PubMed 文献 · Otolaryngol Head Neck Surg · 2023-01-29

基于TriNetX数据库2014至2021年25家医疗机构1813例接受舌下神经刺激器(HNS)植入的阻塞性睡眠呼吸暂停患者,回顾性分析气胸、胸腔积液等并发症及翻修/更换或取出需求。2.4%(44例,来自7个植入中心)发生气胸,0.6%(11例)手术当日诊断胸腔积液;有慢性下呼吸道疾病史者发生气胸的比值比为2.2(95%CI 1.1-4.1,P=0.02)。作者认为术中气胸和胸腔积液发生率可能高于最初预期,慢性下呼吸道疾病患者风险可能增加,应在知情同意过程中告知患者。

要点

  • HNS植入术中气胸发生率为2.4%(44/1813),胸腔积液为0.6%(11/1813)。
  • 有慢性下呼吸道疾病史者发生气胸的OR为2.2(95%CI 1.1-4.1,P=0.02)。
  • 作者认为气胸和胸腔积液发生率可能高于最初预期,应在知情同意时告知患者。

核心结论

  • HNS植入术中气胸和胸腔积液的发生率可能高于最初预期。
  • 有慢性下呼吸道疾病的患者发生气胸的风险可能增加。
  • 作者认为应在知情同意过程中向患者告知这些风险。

研究设计与样本

  • 回顾性病例对照研究,时间为2014年至2021年。
  • 数据来自美国25家医疗机构,通过TriNetX研究网络以疾病代码回顾性识别接受HNS植入的阻塞性睡眠呼吸暂停患者。
  • 共识别1813例接受HNS植入的患者,平均年龄60岁,男性68%、女性32%。

主要发现

  • 2.4%(n=44,来自7个植入中心)的患者发生气胸。
  • 0.6%(n=11)的患者在手术当日诊断胸腔积液。
  • 与无慢性下呼吸道疾病史者相比,有该病史者发生气胸的比值比为2.2(95%CI 1.1-4.1,P=0.02)。

临床怎么用

  • 作者认为术中气胸和胸腔积液发生率可能高于最初预期,应在知情同意过程中与患者沟通。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There have been case reports of adverse events of hypoglossal nerve stimulator (HNS) implantation not seen in previous clinical trials, including pneumothorax and pleural effusion. The purpose of this study was to determine the rates of these complications and potential risk factors. STUDY DESIGN: Retrospective case-control study during 2014 to 2021. SETTING: Twenty-five health care organizations across the United States. METHODS: The TriNetX Research Network was queried by using disease codes to retrospectively identify patients with obstructive sleep apnea who underwent HNS implantation. Rates of pneumothorax, pleural effusion, other complications, and need for revision/replacement or explant were determined. RESULTS: We identified 1813 patients from 25 health care organizations who underwent HNS implantation. The average age was 60 years, and there were 68% males and 32% females. Of the cohort, 2.4% (n = 44 from 7 implant centers) experienced a pneumothorax, and 0.6% (n = 11) were diagnosed with a pleural effusion on the day of surgery. Patients who experienced pneumothorax were more likely to have a history of chronic lower respiratory diseases when compared with those who did not (odds ratio, 2.2; 95% CI, 1.1-4.1; P = .02). CONCLUSION: The incidence of intraoperative pneumothorax and pleural effusion during HNS implantation may be greater than initially thought. Patients with chronic lower respiratory diseases may be at increased risk. This should be communicated with patients during the informed consent process.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Lorenz FJ, Goyal N. Iatrogenic Pneumothorax During Hypoglossal Nerve Stimulator Implantation: A Large Database Analysis. Otolaryngol Head Neck Surg. 2023. PMID: 36066978. doi:10.1177/01945998221122696

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。